← All companies
ELAN
Elanco Animal Health Incorporated
$25.72
-0.74 -2.80%
Key statistics
from XBRL data in SEC filingsMarket cap
$12.8B
Revenue (TTM)
$4.89B
Net income (TTM)
-$242M
EPS (TTM)
$-0.49
P/E ratio
—
Dividend yield
—
Free cash flow
$284M
Cash
$428M
Total assets
$13.2B
Gross margin
55.1%
52-week range
$13.76 – $27.72
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
May 27, 2026
10-Q
Quarter ended 2026-03-31
May 6, 2026
8-K
Results of operations (earnings release)
May 6, 2026
10-K
Fiscal year ended 2025-12-31
Feb 24, 2026
8-K
Results of operations (earnings release)
Feb 24, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
8-K
Exit or disposal costs; Regulation FD disclosure
Dec 9, 2025
10-Q
Quarter ended 2025-09-30
Nov 5, 2025
8-K
Results of operations (earnings release)
Nov 5, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Nov 3, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Jun 26, 2025
8-K
Director or officer change; Regulation FD disclosure
May 28, 2025
8-K
Shareholder vote results
May 21, 2025
10-Q
Quarter ended 2025-03-31
May 7, 2025
8-K
Results of operations (earnings release)
May 7, 2025
8-K
Director or officer change; Regulation FD disclosure
Mar 17, 2025
10-K
Fiscal year ended 2024-12-31
Feb 25, 2025
8-K
Results of operations (earnings release)
Feb 25, 2025
8-K
Regulation FD disclosure
Jan 13, 2025
8-K
Director or officer change; Regulation FD disclosure
Nov 12, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Regulation FD disclosure
Oct 16, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Aug 13, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Completed an acquisition or disposition; Regulation FD disclosure
Jul 9, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Jul 3, 2024
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results
Jun 4, 2024
10-Q
Quarter ended 2024-03-31
May 8, 2024
8-K
Results of operations (earnings release)
May 8, 2024
8-K
Entered a material agreement; Director or officer change; Regulation FD disclosure
Apr 1, 2024
10-K
Fiscal year ended 2023-12-31
Feb 26, 2024
8-K
Results of operations (earnings release); Exit or disposal costs
Feb 26, 2024
8-K
Entered a material agreement; Regulation FD disclosure
Feb 5, 2024
8-K
Regulation FD disclosure
Jan 8, 2024
8-K
Regulation FD disclosure
Jan 2, 2024
10-Q
Quarter ended 2023-09-30
Nov 7, 2023